GLOBE Score for Patient with Primary Biliary Cirrhosis (PBC)

Purpose: To evaluate a patient with primary biliary cirrhosis (PBC) after UDCA therapy using the GLOBE score.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient with PBC who has been treated with UDCA?

Yes

Age at start of UDCA therapy

year of age

Serum total bilirubin after 1 year follow-up

Upper limit of the normal reference range for total serum bilirubin

Serum alkaline phosphatase at 1 year follow-up

IU/L

Upper limit of the normal reference range for serum alkaline phosphatase

IU/L

Serum albumin at 1-year follow-up

Lower limit of normal for serum albumin

Platelet count per 10^9/L at 1 year follow-up

*10^9/L

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

GLOBE score

Transplant free survival at 3 years

Transplant free survival at 5 years

Transplant free survival at 10 years

Transplant free survival at 15 years

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
- Mayo Risk Score in Primary Biliary Cirrhosis
Clinical Diagnosis, Including Family History For Genetics
- Yale Prognostic Score in Primary Biliary Cirrhosis
Other Testing
Criteria For Diagnosis
- Score for Diagnosis of Primary Biliary Cirrhosis (PBC)
Severity, Prognosis, Stage

Therapy

Selection
- Primary Biliary Cirrhosis - AST to Platelet Ratio Index (APRI) & Response to UDCA Therapy for Risk Stratification

Monitoring

Response To Therapy
- Primary Biliary Cirrhosis - AST to Platelet Ratio Index (APRI) & Response to UDCA Therapy for Risk Stratification

Specialty

Gastroenterology
Immunology/Rheumatology

Objective

selection

ICD-10

K74.3 - Primary biliary cirrhosis

Info

Purpose: To evaluate a patient with primary biliary cirrhosis (PBC) after UDCA therapy using the GLOBE score.

Specialty: Gastroenterology, Immunology/Rheumatology

Objective: selection

ICD-10: K74.3,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path